Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases - PubMed (original) (raw)
Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases
Olga Pletnikova et al. Neurobiol Aging. 2005 Aug-Sep.
Abstract
In order to understand better the neuropathological substrate of dementia in Parkinson's disease (PD) and to examine its interactions with Alzheimer's disease (AD), we examined autopsy brains from 21 cases of PD and Lewy body disease (LBD) with dementia. We separated brains in two groups according to the presence of Abeta deposits. In brains without Abeta, we found few or no Lewy bodies (LB) in the cerebral cortex. By contrast, in brains with Abeta, we observed significant increases in LB in the cerebral cortex (p < 0.01) and alpha-synuclein immunoreactive lesions in the cingulate cortex (p < 0.01). Immunoblots of alpha-synuclein from cingulate cortex in brains with Abeta showed significantly higher levels of insoluble alpha-synuclein compared to brains without Abeta. Our observations indicate that in cases of PD with dementia, the neocortex is not necessarily involved by LB. Furthermore, the presence of Abeta deposits in the cerebral cortex was associated with extensive alpha-synuclein lesions and higher levels of insoluble alpha-synuclein. This suggests that Abeta enhances the development of cortical alpha-synuclein lesions in cases of PD.
Similar articles
- Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M. Mattila PM, et al. Acta Neuropathol. 2000 Sep;100(3):285-90. doi: 10.1007/s004019900168. Acta Neuropathol. 2000. PMID: 10965798 - Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA, Jäkälä P, Hartmann T, Havas L, McLean C, Culvenor JG, Li QX, Masters CL, Falkai P, Beyreuther K. Bayer TA, et al. Neurosci Lett. 1999 May 14;266(3):213-6. doi: 10.1016/s0304-3940(99)00311-0. Neurosci Lett. 1999. PMID: 10465711 - Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M, Gelpi E, Martí MJ, Compta Y. Sierra M, et al. Neuropathol Appl Neurobiol. 2016 Aug;42(5):451-62. doi: 10.1111/nan.12308. Epub 2016 Apr 1. Neuropathol Appl Neurobiol. 2016. PMID: 26810462 - Alpha-synuclein, Abeta and Alzheimer's disease.
Wirths O, Bayer TA. Wirths O, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):103-8. doi: 10.1016/S0278-5846(02)00339-1. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12551731 Review. - Amyloid PET Imaging in Lewy body disorders.
Donaghy P, Thomas AJ, O'Brien JT. Donaghy P, et al. Am J Geriatr Psychiatry. 2015 Jan;23(1):23-37. doi: 10.1016/j.jagp.2013.03.001. Epub 2013 Jul 3. Am J Geriatr Psychiatry. 2015. PMID: 23831180 Review.
Cited by
- National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ. Hyman BT, et al. Alzheimers Dement. 2012 Jan;8(1):1-13. doi: 10.1016/j.jalz.2011.10.007. Alzheimers Dement. 2012. PMID: 22265587 Free PMC article. - Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation.
Oueslati A, Ximerakis M, Vekrellis K. Oueslati A, et al. Exp Neurobiol. 2014 Dec;23(4):324-36. doi: 10.5607/en.2014.23.4.324. Epub 2014 Dec 12. Exp Neurobiol. 2014. PMID: 25548532 Free PMC article. Review. - Amyloid-β and Parkinson's disease.
Lim EW, Aarsland D, Ffytche D, Taddei RN, van Wamelen DJ, Wan YM, Tan EK, Ray Chaudhuri K; Kings Parcog groupMDS Nonmotor study group. Lim EW, et al. J Neurol. 2019 Nov;266(11):2605-2619. doi: 10.1007/s00415-018-9100-8. Epub 2018 Oct 30. J Neurol. 2019. PMID: 30377818 Review. - α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment.
Karim MR, Liao EE, Kim J, Meints J, Martinez HM, Pletnikova O, Troncoso JC, Lee MK. Karim MR, et al. Mol Neurodegener. 2020 Apr 16;15(1):27. doi: 10.1186/s13024-020-00364-w. Mol Neurodegener. 2020. PMID: 32299471 Free PMC article. - Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
Schumacher J, Gunter JL, Przybelski SA, Jones DT, Graff-Radford J, Savica R, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Knopman DS, Fields JA, Kremers WK, Petersen RC, Graff-Radford NR, Ferman TJ, Boeve BF, Thomas AJ, Taylor JP, Kantarci K. Schumacher J, et al. Brain. 2021 Nov 29;144(10):3212-3225. doi: 10.1093/brain/awab218. Brain. 2021. PMID: 34114602 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous